You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oral Covalent Menin Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Canada, United States (BMF-219)

Recruiting
  • Type 2 Diabetes Mellitus
  • Montclair, California
  • +5 more
Feb 22, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Primary Membranous Nephropathy Trial (EVER001)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Mar 23, 2023

Advanced Solid Tumors With HER2 Abnormalities, Advanced Solid Tumors With HER3 Abnormalities Trial in Worldwide (TAS0728)

Active, not recruiting
  • Advanced Solid Tumors With HER2 Abnormalities
  • Advanced Solid Tumors With HER3 Abnormalities
  • Duarte, California
  • +7 more
Dec 9, 2021

Type 1 Diabetes Trial (BMF-219)

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • (no location specified)
Nov 21, 2023

Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

Recruiting
  • Malignant Tumor
  • +2 more
  • 68Ga-TCR-FAPI PET/CT
  • Beijing, China
    Peking University Cancer Hospital
Oct 19, 2023

B-Cell Malignancies Trial (TT-01488 Tablets)

Not yet recruiting
  • B-Cell Malignancies
  • TT-01488 Tablets
  • (no location specified)
Jan 4, 2023

B-Cell Malignancies Trial in Canton, Houston (TT-01488)

Recruiting
  • B-Cell Malignancies
  • Canton, Ohio
  • +1 more
Jun 8, 2022

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Epidemic Meningitis Trial (MCV4)

Not yet recruiting
  • Epidemic Meningitis
  • MCV4
  • (no location specified)
Jul 5, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Healthy Trial in Biberach (BI 1810631, Itraconazole)

Recruiting
  • Healthy
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Apr 27, 2023

Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3915 tablets
  • Guangzhou, Guangdong, China
  • +2 more
Jun 9, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • (no location specified)
Aug 4, 2023

Endotracheal Intubation Trial in Würzburg (Conventional direct laryngoscopy (CDL), Video assisted laryngoscopy with

Recruiting
  • Endotracheal Intubation
  • Conventional direct laryngoscopy (CDL)
  • +2 more
  • Würzburg, Germany
    University Hospital Wuerzburg
Apr 11, 2022

Cholangiocarcinoma Metastatic Trial in China (TT-00420 (tinengotinib))

Not yet recruiting
  • Cholangiocarcinoma Metastatic
  • TT-00420 (tinengotinib)
  • Guangzhou, Guangdong, China
  • +6 more
Sep 26, 2023

Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Burgas, Bulgaria
  • +19 more
Oct 20, 2022

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +3 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 7, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +4 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 2, 2023

Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

Not yet recruiting
  • Colorectal Cancer
  • +8 more
  • (no location specified)
Jan 5, 2023

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

Not yet recruiting
  • Rhabdoid Tumor
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 11, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023